Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).

ME O'Brien; T Splinter; E.F. Smit; B. Biesma; M Krzakowski; VC Tjan-Heijnen; A Van Bochove; J Stigt; MJ Smid-Geirnaerdt; C. Debruyne; C Legrand; G. Giaccone

doi:10.1016/S0959-8049(03)00319-8

Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).

ME O'Brien
, T Splinter
, E.F. Smit
, B. Biesma
, M Krzakowski
, VC Tjan-Heijnen
, A Van Bochove
, J Stigt
, MJ Smid-Geirnaerdt
, C. Debruyne
, C Legrand
, G. Giaccone

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1416-22
Journal	European Journal of Cancer
Volume	39
Issue number	10
DOIs	https://doi.org/10.1016/S0959-8049(03)00319-8
Publication status	Published - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0959-8049(03)00319-8

Cite this

O'Brien, ME., Splinter, T., Smit, E. F., Biesma, B., Krzakowski, M., Tjan-Heijnen, VC., Van Bochove, A., Stigt, J., Smid-Geirnaerdt, MJ., Debruyne, C., Legrand, C., & Giaccone, G. (2003). Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958). European Journal of Cancer, 39(10), 1416-22. https://doi.org/10.1016/S0959-8049(03)00319-8

@article{a18c3e282f8147e59778e89328ca695a,

title = "Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).",

author = "ME O'Brien and T Splinter and E.F. Smit and B. Biesma and M Krzakowski and VC Tjan-Heijnen and \{Van Bochove\}, A and J Stigt and MJ Smid-Geirnaerdt and C. Debruyne and C Legrand and G. Giaccone",

year = "2003",

doi = "10.1016/S0959-8049(03)00319-8",

language = "English",

volume = "39",

pages = "1416--22",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "10",

}

O'Brien, ME, Splinter, T, Smit, EF, Biesma, B, Krzakowski, M, Tjan-Heijnen, VC, Van Bochove, A, Stigt, J, Smid-Geirnaerdt, MJ, Debruyne, C, Legrand, C & Giaccone, G 2003, 'Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).', European Journal of Cancer, vol. 39, no. 10, pp. 1416-22. https://doi.org/10.1016/S0959-8049(03)00319-8

TY - JOUR

T1 - Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).

AU - O'Brien, ME

AU - Splinter, T

AU - Smit, E.F.

AU - Biesma, B.

AU - Krzakowski, M

AU - Tjan-Heijnen, VC

AU - Van Bochove, A

AU - Stigt, J

AU - Smid-Geirnaerdt, MJ

AU - Debruyne, C.

AU - Legrand, C

AU - Giaccone, G.

PY - 2003

Y1 - 2003

U2 - 10.1016/S0959-8049(03)00319-8

DO - 10.1016/S0959-8049(03)00319-8

M3 - Article

SN - 0959-8049

VL - 39

SP - 1416

EP - 1422

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 10

ER -